◆英語タイトル：3D Laparoscopy Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
The 3D Laparoscopy Imaging Market is expected to register a CAGR of nearly 4.5% over the forecast period.
With the outbreak of COVID-19, 3D laparoscopy procedures have seen renewed focus as studies have shown that patients who had undergone bariatric surgeries had a lower risk of hospital and intensive care unit (ICU) admissions. Researchers at the Cleveland Clinic had commissioned a study in November 2020 and came up with the above observations. This is likely to increase demand for bariatric procedures which will eventually positively affect demand for 3D laparoscopy devices. The factors which are driving market growth include increasing preference for and advancements of 3D imaging technology, increase in obesity and rising demand for bariatric surgeries, and rising demand for minimally invasive procedures.
The demand for minimally invasive procedures is also rising due to its convenience. Minimally invasive surgeries (MIS) cause less post-operative pain and hence, patients receive smaller dosages of pain killers. As there are lesser cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. The costs for conducting MIS is also very low. In one of researches conducted by Medtronic recently, the cost-effectiveness of MIS was compared with open surgery (OS) techniques for one- and two-level lumbar spinal fusion in the treatment of degenerative lumbar spinal conditions. The research was conducted jointly in the United Kingdom and Italy. It was observed that the total cost saving per procedure was significantly lower than OS. MIS procedures use 3D laparoscopy imaging devices abundantly due to their convenience. In addition, conventional laparoscopic camera consists of only a 2-Dimensional (2D) system and although there is an improvement in graphics from high definition (HD) system, there is still a lack of depth and spatial perception. 3-Dimensional (3D) systems can potentially improve laparoscopic training by eliminating the need to overcome the loss of stereoscopic vision. Increase in demand for minimally invasive procedures is likely to affect market growth in a positive manner.
Key Market Trends
Bariatric Surgery is Expected to Hold Significant Market Share By Application over the Forecast Period
The COVID-19 pandemic is likely to have a positive impact on the market. According to a study appearing in Medscape in December 2020, patients with obesity who had lost weight after bariatric surgery and then contracted COVID-19 were less likely to be admitted to the hospital for COVID, and the disease was less severe than among COVID patients with obesity who had not undergone the surgery. Obesity is a metabolic dysfunction and is often associated with a wide range of chronic illnesses, which cause significant increases in mortality and comorbidity. This is likely to affect the market development for 3D laparoscopy imaging devices in a positive manner.
According to the WHO (World Health Organization), in 2019 an estimated 38.2 million children under the age of 5 years were overweight or obese. Moreover, these numbers were expected to increase exponentially in the near future. Almost about half of the children under 5 who were overweight or obese in 2019 lived in Asia. According to a 2018 Europa report, more than half the population was overweight in 34 out of 36 OECD countries and almost one in four people were obese. The report also stated that overweight related disorders will claim as many as 92 million lives in the OECD with obesity and overweight-related diseases reducing life expectancy by nearly 3 years by 2050.
According to worldobesity.org, in 2018, the prevalence of obesity was significantly high in developed countries like the United States (42.8%), Australia (31.3%) and Belgium (21.20%) as compared to developing countries like India (4.10%). However, countries in the Pacific islands like American Samoa (74.6%) have some of the highest obesity rates in the world. In addition to this, developing countries have higher disease burden for obesity due to which the market for 3D laparoscopy imaging is expected to increase in these countries.
Obesity is also associated with substantial increases in premature mortality, impaired quality of life, and substantial costs of healthcare. The major comorbidities include hypertension, Type-2 diabetes dyslipidaemia, myocardial infarction, certain cancers, stroke, sleep apnea, and osteoarthritis. Most of the comorbidities are the leading causes of death too. Hence, increased prevalence of obesity and the resulting diseases have created a burden among the population, worldwide, both in developing and developed economies. 3-dimensional (3-D) technologies have been introduced in an attempt to improve surgeon vision and thus increase the safety of the bariatric surgical techniques, thus driving the growth of the segment in the market.
North America Dominates the Market and Similar is Expected over the Forecast Period
The number of people suffering from obesity in America have been increasing. The Centers for Disease Control and Prevention (CDC) estimated that the prevalence of obesity was 42.4% in 2017~2018, according to its CDC National Center for Health Statistics (NCHS) data brief. The study also pointed out that the proportion of adults who were overweight, including being obese was 73.6%. As obesity is linked to an increasing number of bariatric surgeries performed each year, with the rising prevalence of obesity, bariatric surgery has proven to be effective in its treatment.
In a November 2020 Cleveland Clinic study, researchers were able to show that in obese people who had tested positive for COVID-19, a past history of bariatric surgery was associated with a significantly lower risk of hospital and intensive care unit admission. Thus, obese people would now be more inclined towards conducting bariatric surgeries, thereby creating demand for 3D laparoscopy imaging devices.
In a national survey conducted in 2018 in Mexico, 36·1% of adults had obesity with a substantially higher prevalence in women than in men (40·2% and 30·5% respectively). High prevalence of obesity in the Mexican population is expected to lead to a greater number of bariatric surgeries which will fuel the demand for 3D laparoscopy imaging. According to the American Society for Metabolic and Bariatric Surgery 2018 statistics, the total number of metabolic and bariatric procedures performed in 2018 increased from approximately 228,000 to 252,000 in the United States alone. This represented a 10.8% increase in the number of procedures in 2018. These statistics show an increase in the number of bariatric surgeries, which drives the growth of the overall market. Also, according to the National Institute of Diabetes and Digestive and Kidney Diseases in the United States, in 2018, the major annual expenditures under Medicare beneficiaries were majorly for prostate cancer, interstitial cystitis, lower tract transitional cell carcinoma, urinary tract stones, urethral stricture, and urinary tract infections. Hence, the rising demand for 3D laparoscopic imaging for bariatric and urologic surgeries is expected to propel the market growth in the region.
The global 3D Laparoscopy Imaging market is moderately competitive and consists of a few major players. Companies like Olympus Corporation, Sometech, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, Fujifilm Healthcare, Medtronic, Siemens Healthineers, among others, hold the substantial market share in the 3D Laparoscopy Imaging market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for and Advancements of 3D Imaging Technology
4.2.2 Rise in Obesity and Increase in Demand for Bariatric Surgeries
4.2.3 Rising Demand for Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 High Cost Associated with the Products
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Gynecological Surgery
5.1.2 Bariatric Surgery
5.1.3 Urological Surgery
5.2 By End User
5.2.2 Ambulatory Surgical Centers
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 Sometech Inc.
6.1.3 Karl Storz SE & Co. KG
6.1.4 B. Braun Melsungen AG
6.1.5 Conmed Corporation
6.1.6 Medtronic Plc
6.1.7 Siemens Healthineers
6.1.8 Johnson & Johnson Medical Devices
6.1.9 Stryker Corporation
6.1.10 Richard Wolf GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS